Tulsi Gabbard Resigns as US National Intelligence Director Potential Implications for National Security and Defense Sector Jim Cramer Highlights Silly Aspects of Arm Holdings Valuation Japans Food Industry Faces Bleak Outlook as War and Demographic Decline Squeeze Margins Netflixs The Boroughs from Duffer Brothers Shows Initial Promise Then Declines Content Quality Concerns Elon Musks X Fined A650000 by Australian Court for Child Protection Law Breaches Gold Under Pressure Bearish Momentum Builds as Potential Test of 4444 Comes into Focus SBC Medical Group Holdings Q1 2026 Earnings EPS Beat Amid Market Skepticism IQST Q4 2025 Earnings Deep EPS Miss as Losses Widen Revenue Data Unavailable Hinge Health HNGE Q1 2026 Earnings EPS Beats by 163 Stock Moves Higher Freedom Holding Corp FRHC Q1 2026 Earnings EPS of 125 Surpasses Expectations Amid Solid Operational Performance MCRI Q1 2026 Earnings EPS Surges Past Estimates with 349 Beat FSBC Q1 2026 Earnings EPS Beats Expectations Despite Flat Stock Reaction Pimco High Income Fund PHK Edges Higher Amid Tight Trading Range Medtronic MDT Holds Steady Near Support as Bullish Momentum Builds BingEx Limited FLX Edges Higher Amid Support Test Polyrizon Ltd PLRZ Posts Modest Gain as Stock Consolidates Near Support Levels AMC Robotics Corporation AMCI Stock Declines Sharply as Selling Pressure Intensifies US Seeks to Advance American AI Integration in Asia Following TrumpXi Meeting AdaptHealth Corp AHCO Q1 2026 Earnings EPS Miss Mirrors Operational Strain Star Equity Holdings STRR Edges Higher Key Levels and Momentum in Focus Australian Oilseeds Holdings COOT Declines 3 as Stock Approaches Critical 060 Support Sharplink Inc SBET Declines 386 as Stock Nears Key Support at 592 Seres Therapeutics MCRB Edges Higher Amid Steady Support and Resistance Dynamics Miami International Holdings MIAX Edges Higher Testing Key Resistance Levels Douglas Elliman DOUG Dips Slightly Holds Above Key Support Amid Housing Market Uncertainty iQSTEL Inc IQST Faces Resistance After Pullback from Key Level GT Biopharma Inc GTBP Falls Over 10 as Biotech Sentiment Weakens